BAXFENDY FDA approval date

The FDA approved BAXFENDY on 15 May 2026.

FDA approval date
15 May 2026

Drug identity has not yet been verified against registry records

Also recorded as BAXDROSTAT

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-05-15DayBAXFENDYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219878", "applicant_as_listed_by_fda": "ASTRAZENECA AB", "brand_names": ["BAXFENDY"], "active_ingredients": ["BAXDROSTAT"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260515", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026